BIOTECH

BIOTECH

Doron Therapeutics Announces Positive End-of-Phase 2 and Initial RMAT Meeting With FDA for MOTYS (PTP-001) in the Treatment of Knee Osteoarthritis

CHAPEL HILL, NORTH CAROLINA / ACCESS Newswire / May 20, 2025 / Doron Therapeutics, a clinical-stage biotechnology company...

Read more

BIOTECH

Azalea Vision Raises €9 Million in First Closing of Series A to Further Develop Intelligent Connected Vision Platform

GHENT, Belgium–(BUSINESS WIRE)–Azalea (A-zuh-lay-ah) Vision, a HealthTech company engineering the future of sight, today announced the...

Read more

BIOTECH

Cadwell Makes a Strategic Investment in Seer Medical to Expand Home-Based Epilepsy Diagnostics

KENNEWICK, Wash., April 15, 2025 /PRNewswire/ — Cadwell Industries, Inc., a global leader in neurodiagnostic, neuromonitoring, and sleep...

Read more

BIOTECH

PulseSight Therapeutics Announces First Close of its Series A Financing to Fund Clinical Development of PST-611 in dry AMD

PARIS, Feb. 13, 2025 (GLOBE NEWSWIRE) — PulseSight Therapeutics SAS, an ophthalmology biotech company developing...

Read more

BIOTECH

RheumaGen, Inc. Launches with $15 Million Series A Financing to Advance a New Class of HLA Gene-Editing Therapies for Major Autoimmune Diseases

Company focused on editing the human leukocyte antigen (HLA) to transform autoimmunity Lead program, RG0401,...

Read more